Overcoming Animal Testing with Advanced Cell Models

Organoids and microtissues hold significant promise for reducing or even replacing animal testing in a range of sectors, including human health and life sciences. These cell systems better mimic human biology, providing more accurate predictions of drug responses, toxicity, and disease mechanisms. Nevertheless, there are still substantial challenges to address. This panel will discuss these challenges, including the workflows, tools and regulatory guidance needed to realise the full potential.